site stats

Incyte sec filings

WebIncyte Corp. SEC filings breakout by MarketWatch. View the INCY U.S. Securities and Exchange Commission reporting information. Skip to main contentMain Menu Home Latest News Watchlist... WebFind the latest SEC Filings data for Incyte Corp. Common Stock (INCY) at Nasdaq.com.

Incyte Corp. – Filings and Transcripts – BamSEC

WebAug 20, 2024 · Incyte Corp (INCY) SEC Filing 8-K Material Event for the period ending Wednesday, August 18, 2024. Home. SEC Filings. Incyte Corp (INCY) 8-K Material Event Fri Aug 20 2024 ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe … WebApr 13, 2024 · The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Maria E. Pasquale sold 60,024 shares of Incyte stock in a transaction that occurred on Monday, January 30th. The stock was sold at an average price of $84.74, for a total value of $5,086,433.76. lockup gaston county nc https://dacsba.com

SEC.gov SEC Charges Biopharmaceutical Company Employee

WebIncyte Corp. SEC filings breakout by MarketWatch. View the INCY U.S. Securities and Exchange Commission reporting information. Skip to main contentMain Menu Home … WebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. (NASDAQ:INCY – Get Rating) in the 4th quarter, according to its most recent Form 13F … WebApr 11, 2024 · Exchange Traded Concepts LLC decreased its position in Incyte Co. (NASDAQ:INCY - Get Rating) by 7.5% during the 4th quarter, according to the company in … indigenous worldview canada

Peggy Scherle, Ph.D. - Prelude Therapeutics

Category:0001558370-22-006808 10-Q Incyte - Incyte Corporation

Tags:Incyte sec filings

Incyte sec filings

Incyte Corp (INCY) 8-K Earnings Release - Nov 2024

WebApr 12, 2024 · Ballentine Partners LLC acquired a new position in shares of Incyte Co. ( NASDAQ:INCY - Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 2,609 shares of the biopharmaceutical company's stock, valued at approximately $210,000. 3 S&P 500 … WebApr 6, 2024 · Incyte Corp. – Filings and Transcripts – BamSEC Incyte Corp. Watch NASDAQ: INCY Share price (3/29/23): $71.14 Market cap (3/29/23): $15.9 billion 8 Incyte Corp. …

Incyte sec filings

Did you know?

WebOct 4, 2024 · INCY SEC Filings - Incyte Corporation - Annual Report, Proxy Statement, Prospectus. ... SEC Filings All companies that sell securities in the United States must … WebLilly and Incyte Announce Collaboration for Development and Commercialization of Oral Anti-Inflammatory and Autoimmune Therapies. December 21, 2009 ... Incyte's dependence on its relationship with its collaboration partners, and other risks detailed from time to time in Incyte's filings with the Securities and Exchange Commission, including its ...

WebNov 1, 2024 · Incyte Corp (INCY) SEC Filing 8-K Material Event for the period ending Tuesday, November 1, 2024 WebFeb 8, 2024 · Incyte Corp (INCY) SEC Filing 10-K Annual Report for the fiscal year ending Friday, December 31, 2024 Home SEC Filings Incyte Corp (INCY) 10-K Annual Report Tue …

WebOct 25, 2024 · Incyte gains exclusive, worldwide development and commercialization rights to MGA012 in all indications; ... the availability or commercial potential of MacroGenics' product candidates and other risks described in MacroGenics' filings with the Securities and Exchange Commission. In addition, the forward-looking statements included in this press ... WebFeb 7, 2024 · Incyte Corp (INCY) SEC Filing 8-K Material Event for the period ending Tuesday, February 7, 2024. HOME; LOGIN; PREMIUM; FREE TRIAL; SEC FILINGS; STOCK SCREENERS.

WebSEC Filings Incyte Corp (INCY) 10-K Annual Report Tue Feb 07 2024 10-Q Quarterly Report May 2024 10-Q Quarterly Report November 2024 10-Q Quarterly Report August 2024 10-Q …

WebApr 9, 2024 · The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Incyte news, EVP … lockup host cpu usageWebApr 11, 2024 · Strs Ohio’s holdings in Incyte were worth $2,095,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors have also recently made changes to their ... lock upgrading and downgrading in dbmsWebScherle was one of the original team of scientists that joined Incyte in 2002 and was involved in the discovery and development of the JAK inhibitors, Jakafi® (ruxolitinib), for the treatment of myelofibrosis and polycythemia vera, and Olumiant® (baricitinib), for rheumatoid arthritis, as well as the advancement of >10 small molecules into … indigenous worldview examplesWebApr 4, 2024 · Filing date Form Description View; Apr 04, 2024: 4: Statement of changes in beneficial ownership of securities. View HTML indigenous worldviews and perspectivesWebApr 13, 2024 · China Universal Asset Management Co. Ltd. lifted its stake in Incyte Co. ( NASDAQ:INCY – Get Rating) by 8.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. lockup grand finaleWebApr 9, 2024 · Dupont Capital Management Corp lifted its position in shares of Incyte Co. (NASDAQ:INCY - Get Rating) by 215.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.The institutional investor owned 9,032 shares of the biopharmaceutical company's stock after … indigenous worldviews includeWebIncyte is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware, and Morges, Switzerland. ... SEC filings; Yahoo! This page was last edited on 19 December 2024, at 02:24 (UTC). Text … lockup handlebars heper